Bio-Techne Art Director Salaries in Baltimore, MD | Comparably
Bio-Techne Claimed Company
Bio-Techne provides scientific solutions. read more
EMPLOYEE
PARTICIPANTS
74
TOTAL
RATINGS
769
HR or Marketing? Claim Your Free Employer Account

Bio-Techne Art Director Salaries in Baltimore, MD

The average Bio-Techne Art Director in Baltimore, MD earns an estimated $101,383 annually. Bio-Techne's Art Director compensation is $3,999 more than the US average for a Art Director.

In Baltimore, MD, The Design Department at Bio-Techne earns $5,325 more on average than the Sales Department.

Last updated a year ago.

$27k
$48k
$69k
$90k
$232k
$489k
$505k
$101,383
Average Compensation
$101,383
avg. base

Art Director Salaries at Bio-Techne

In Baltimore, MD, Art Directors earn $1,897 more than UI/UX Designers, and $20,089 less than Senior Designers.

Principal Designer
$166k*
Creative Director
$162k*
Senior UI/UX Designer
$122k*
Senior Designer
$121k*
UI/UX Designer
$99k*
Web/Visual Designer
$73k*
Designer
$68k*
Graphic Designer
$60k*
* estimated salary

Compensation at Bio-Techne by Department

In Baltimore, MD, The Design Department averages $5,325 more than the Sales Department, and $21,582 less than the HR Department

HR
$138,036 Avg. total comp.
+$22k
Design
$116,454 Avg. total comp.
Sales
$111,129 Avg. total comp.
-$5k

Art Director Compensation by Gender (All Companies)

The average female Art Director at companies similar size to Bio-Techne reported making $96,251, while the average male Art Director at similar sized companies reported making $127,222.

Art Director Compensation by Ethnicity (All Companies)

The average Hispanic or Latino Art Director at companies similar size to Bio-Techne reported making $151,333, while the average African American/Black Art Director at similar sized companies reported making $82,500.

How Art Directors at Bio-Techne Rate Their Compensation

The majority of Art Directors at Bio-Techne believe they're not compensated fairly. 50% of Art Directors at Bio-Techne say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Bio-Techne

×
Rate your company